COVID-19 Updates and Resources

NASTAD continues to closely monitor the rapidly evolving public health responses to mitigate coronavirus disease (COVID-19) in the United States. We are committed to providing NASTAD members with potentially useful information, as it becomes available, to help ensure the continuity of essential programming and the protection of people living with and vulnerable to HIV infection and viral hepatitis.

If you have any questions or additional resources for this page, please email covid19@NASTAD.org.

Last Updated: June 10, 2020

Table of Contents

National Updates

  • Evaluation of HIV Treatments for COVID-19  
  • COVID-19 Testing 
  • Antiretroviral (ARV) and Direct Acting Antiviral (DAA) Supply Chains
  • Insurance Fraud and Scams 
  • Health Department Staffing Impact

Program Updates

  • RWHAP Considerations and Resources
  • Viral Hepatitis Program Resources  
  • Syringe Services Programs (SSPs) and Drug User Health Resources
  • Prevention Program Resources

Policy Updates

  • Legislative and Regulatory Responses

Ensuring Health Equity

  • Incarcerated Individuals and COVID-19
  • COVID-19-Related Xenophobia, Racism, and Stigma
  • Nondiscrimination in Access to Ventilators and other Medical Interventions 

Resources

  • Additional COVID-19 Resources
  • Federal Guidance/Resources
  • Multi-Language Resources

Newest Updates

Prevention Program Resources

In the midst of addressing the global COVID-19 pandemic, health departments and community-based organizations are continuing to address HIV prevention strategies and respond to the national HIV epidemic. Several national partners have developed resources on HIV + COVID-19, safer sex strategies during COVID-19, and testing and treatment options.

Click here to access the resources. NASTAD will update and add resources on COVID’s impact on HIV prevention as they become available.